A retrospective study assessing the clinical outcomes of adult acute lymphoblastic leukemia patients treated on the GMALL protocol and establish prognostic parameters associated with long term survival and risk of relapse in real world settings
Latest Information Update: 11 Jan 2021
At a glance
- Drugs Blinatumomab (Primary) ; CAR-T cell therapies (Primary) ; Inotuzumab ozogamicin (Primary) ; Nelarabine (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 11 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology